Varda raised $251 million in Series D funding to increase launch cadence and advance space-manufactured pharmaceuticals.
- Amount
- $251M
- Stage
- Series D
- Announced
- 30 September 2026
- Leads
- Lux Capital, Natural Capital
- Other investors
- Founders Fund, Khosla Ventures, Caffeinated Capital, General Catalyst, 8090 Industries, Giant Step, Also Capital
- Use of funds
- Increase cadence, deepen pharmaceutical partnerships, get closer to delivering the first medicine made in space.
- Total raised
- $598M to date
- Checked
- Announced by the company